Air vs. Cutaneous Control Mode for Preterm Infants ≤ 32 WG in Incubators: Impact on Body Growth and Morbidity

NCT ID: NCT03919188

Last Updated: 2025-05-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

164 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-01-01

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Previous studies have shown that mortality and morbidity in preterm neonates are correlated with the fall in body temperature on admission. Hypothermia can be decreased by reducing body heat losses to the environment. The investigator research hypothesis is that a new calculation of the air temperature in the incubator would promote the newborn infant weight growth from the period between birth and day 10 of life compared to cutaneous mode. The secondary hypotheses assumes a decrease in the side effects usually observed in both morbidity and mortality.

A software is used to calculate the body heat loss (BHL) of each individual preterm infant, and to propose a specific air temperature setting inside the incubator to reduce BHL to zero. This software has been validated in a previous pilot study (Degorre et al. 2015). This study aims to compare the energy costs of providing incubated preterm infants born between 25 and 32 weeks of gestation with homeothermia using either specific individualized air temperature control (ATC) or skin servocontrol (SSC).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Preterm Infant Body Temperature

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

air temperature control (ATC)

Incubator control using air temperature control (ATC) method

Group Type ACTIVE_COMPARATOR

air temperature control (ATC)

Intervention Type PROCEDURE

Currently there are no guidelines for setting incubator parameters. The Cochrane database point out for further research (Sinclair, 2002). The investigators aim at evaluating 3 different incubator settings for the INOTHERM incubator (Mediprema, France): second parameter : air temperature control (ATC)

skin servocontrol (SSC)

Incubator control using skin servocontrol method

Group Type ACTIVE_COMPARATOR

skin servocontrol (SSC)

Intervention Type PROCEDURE

Currently there are no guidelines for setting incubator parameters. The Cochrane database point out for further research (Sinclair, 2002). The investigators aim at evaluating 3 different incubator settings for the INOTHERM incubator (Mediprema, France): Third parameter : skin servocontrol (SSC).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

air temperature control (ATC)

Currently there are no guidelines for setting incubator parameters. The Cochrane database point out for further research (Sinclair, 2002). The investigators aim at evaluating 3 different incubator settings for the INOTHERM incubator (Mediprema, France): second parameter : air temperature control (ATC)

Intervention Type PROCEDURE

skin servocontrol (SSC)

Currently there are no guidelines for setting incubator parameters. The Cochrane database point out for further research (Sinclair, 2002). The investigators aim at evaluating 3 different incubator settings for the INOTHERM incubator (Mediprema, France): Third parameter : skin servocontrol (SSC).

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* preterm infant born between 25+0 and 32+0 weeks of gestation
* preterm infant included in the study before 24 +/- 12 hours of life
* preterm infant nursed in a closed incubator
* written informed consent from his parents

Exclusion Criteria

* newborn infant with polymalformative syndrome
* life threatening events or serious heart disease
Maximum Eligible Age

1 Day

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Rouen

OTHER

Sponsor Role collaborator

University Hospital, Caen

OTHER

Sponsor Role collaborator

University Hospital, Lille

OTHER

Sponsor Role collaborator

Centre Hospitalier Arras

OTHER

Sponsor Role collaborator

Centre Hospitalier de Montreuil

UNKNOWN

Sponsor Role collaborator

Centre Hospitalier Universitaire, Amiens

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Alexandre Cénéric, Dr

Role: PRINCIPAL_INVESTIGATOR

CHU CAEN

Kévin Leduc, Dr

Role: PRINCIPAL_INVESTIGATOR

CHRU LILLE

Sophie Galène, MD

Role: PRINCIPAL_INVESTIGATOR

CHU Rouen

Guillaume ESCOURROU, MD

Role: PRINCIPAL_INVESTIGATOR

CHI André Grégoire - Montreuil

Julien Ghesquière, MD

Role: PRINCIPAL_INVESTIGATOR

CH Arras

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Amiens University Hospital

Amiens, Picardie, France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Pierre Tourneux, Pr

Role: CONTACT

(33)322087604

Momar Diouf, Dr

Role: CONTACT

(33)322088371

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Pierre Tourneux, MD

Role: primary

+33 3 22 66 82 86

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PI2018_843_0056

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.